Melbourne, Australia; Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) will present to more than 300 sophisticated and institutional investors as part of the ASX Spotlight Conference in Hong Kong and Singapore this week.

The ASX Spotlight Conference is an opportunity to showcase the Company and its products to investors in Asia and to engage with the global investment community.

The conference, now in its ninth year, is attended by a wide range of investors, including global fund representatives, high net worth family offices and regional institutional investors. Starpharma will also participate in one-on-one meetings with investors as part of the conference.

“Starpharma welcomes this opportunity to present the Company’s business and recent achievements to investors in both Hong Kong and Singapore. This is a great opportunity to introduce new investors to the Company and to update existing investors from Asia on recent progress,” said CEO Dr Jackie Fairley.

Starpharma’s presentation will take place on:

• Tuesday 25^th October 2016 at 1:50pm in the Atrium Room, Island Shangri-La, Hong Kong
• Thursday 27^th October 2016 at 10:20am in the Gallery Room, Grand Hyatt, Singapore

View Presentation: Starpharma ASX Spotlight Series Asia Oct 2016 ( pdf file, 1MB)

Download Announcement: Starpharma to present at ASX Spotlight in Asia ( pdf file, 174kb)